ANDREW LEE to Botulinum Toxins, Type A
This is a "connection" page, showing publications ANDREW LEE has written about Botulinum Toxins, Type A.
Connection Strength
0.680
-
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins (Basel). 2021 01 21; 13(2).
Score: 0.573
-
Alleviating Maneuvers for Benign Essential Blepharospasm and Hemifacial Spasm. JAMA Ophthalmol. 2016 11 01; 134(11):1253-1254.
Score: 0.107